AI in clinical trials

Digital

Protocol documentation will become protocol ingestion – an approach that’s automated, consistent, and intelligent.

Digital

Even modest improvements in early predictive resolution can materially shift portfolio economics.

R&D

Rob DiCicco, vice president of portfolio management at Transcelerate Biopharma Inc, discusses barriers and the breakthroughs in making AI work.

R&D

The future of clinical trials isn’t about replacing people. It’s about empowering them with smarter tools.

R&D

SCOPE 2026 was dominated by one big topic: AI. You couldn’t walk five steps without hearing about something that AI was going to fix.

R&D

AI is being used from protocol design to study start-up and through clinical trial closeout, reshaping the trial lifecycle.